Lesson 19: Dose-response-time analysis<https://www.linkedin.com/groups/8614342/8614342-6292623026630594560>
Thursday, July 27th at 10 am EDT we are modeling bacterial growth and death data for a data set that is typical of a preclinical setting. A simple base model is extended to include baseline growth. Please sign up here for the webinar (if you haven't done it already): http://lp.certara.com/WBN2017-07-27Dose-Response_LP-Registration.html<https://www.linkedin.com/redir/redirect?url=http%3A%2F%2Flp%2Ecertara%2Ecom%2FWBN2017-07-27Dose-Response_LP-Registration%2Ehtml&urlhash=K2fR&_t=tracking_anet> You can also freely access the forum to review this lecture series as well as other interesting topics e.g. a series of lectures comparing NONMEM with PML. Remember to follow topics/forums that you wish to hear more from. https://support.certara.com/forums/forum/34-pml-school/ Best regards, Simon. Simon DAVIS Senior Scientific Consultant Work Mobile : +44 7500 190 212 >> note the new number! Facsimile : +1 801 991 7145 Personal Mobile : +44 7980 832 666 simon.da...@certara.com<mailto:simon.da...@certara.com> Get tips and discuss Phoenix with other users; https://support.certara.com/forums/ ______________________________________________________________________ http://www.certarauniversity.com/lms/ (some upcoming courses in EU, full list is here; https://certara-training.s3.amazonaws.com/LMS/website/files/phoenix/schedule/2017-CertaraUniversity-Public-Schedule.pdf) PAGE Workshop - Advanced NLME 5-6 June 2017, Budapest, Hungary Intro to Phoenix WinNonlin, 19-21 Sep 2017, Amsterdam, Netherlands Intermediate Population Modeling Methodology using Phoenix NLME 3-4 Oct 2017, Crete, Greece Advanced Population Modeling Methodology using Phoenix NLME 5-6 Oct 2017, Crete, Greece Intermediate PKPD with Phoenix (Mon-Thur) 17-20 Oct, London UK Intro to Phoenix WinNonlin, 7-9Nov 2017, London, UK Intro to Phoenix NLME (Tue-Wed) 9-10 Nov, London, UK Intro to Phoenix WinNonlin, 5-7 Dec 2017, Frankfurt, Germany Phoenix WinNonlin IVIVC 7-8 Dec 2017, Frankfurt, Germany NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
